April 24, 2014
AWHONN SmartBrief
Your bi-weekly resource for clinical news and career development
Sign up|Forward|Archive|Advertise

AWHONN SmartBrief special report:
Congenital heart disease, Part II
About 1.3 million people in the U.S. have congenital heart defects, according to the American Heart Association. The condition affects 35,000 newborns annually, or 8 out of every 1,000 births, according to the National Heart, Lung and Blood Institute. The seven most severe defects -- critical congenital heart disease -- can affect the interior walls of the heart, important veins and arteries and the cardiac valves. This AWHONN SmartBrief special report looks at news and resources related to congenital heart defects. Part I was published on April 15.
Patients' Perspective 
  • Mom shares girl's journey to help others with heart defects
    The news that their baby Vayda would have to undergo heart surgery was hard for Amanda and Jonathan Evans to hear in April 2012, but they're grateful for their daughter's progress and her ability to serve as the honorary leader of heart walks in northeast Pennsylvania. Vayda was diagnosed with tetralogy of Fallot and was able to return home days after her surgery. "We never realized until having to go through this how many children are affected by congenital heart birth defects, and anything we can do to help someone through this experience, and spread the importance of heart health, we will continue to do," Amanda Evans said. The Times-Tribune (Scranton, Pa.) (tiered subscription model) (4/5) Email this Story
  • U.K. man keeps on walking for awareness and research
    A 59-year-old British man who has had three surgeries for his congenital heart disease was inspired to show how far treatment can help someone go by walking nonstop for 26 hours to support a heart charity. Gary Glazerman underwent his first open-heart procedure at the age of 5 and credits research and awareness about congenital heart disease with helping him and other heart patients. Harrow Times (U.K.) (3/22) Email this Story
CCHD Screening Saves Lives
Masimo SET® pulse oximeters and sensors meet the recommended criteria for newborn screening, were exclusively used in the two studies that were the basis for the CCHD Workgroup decision to recommend newborn screening, and were the first to receive FDA 510(k) clearance with labeling for CCHD screening. Learn more.
Trends and Technology 
  • BMI may interfere with fetal cardiac ultrasound evaluation
    It's possible that the fetus of an overweight mother may not get a comprehensive cardiac ultrasound, and congenital cardiac defects could be missed as a result. A study from Sweden found that six or more of 10 serious cardiac defects in fetuses are undetected in overweight mothers. A body mass index over 30 makes ultrasound exam of the fetus difficult, according to the study. The Times of India/TNN (3/14) Email this Story
  • White blood cells could treat cytomegalovirus-infected cells
    Cells infected by cytomegalovirus, which can cause congenital birth defects, can be killed by a protein produced by neutrophils, a type of white blood cell, according to research conducted at the Cardiff University and other facilities. "Disease may actually be prevented if we can teach the immune system to quickly send antiviral neutrophils to the first site of infection. We are now developing a vaccine that may protect the body against CMV," Dr. Ian Humphreys said. BBC (4/10) Email this Story
  • Other News
AWHONN Resources 
  • Webinar recording: CCHD Screening Using Pulse Oximetry
    Did you know that a 2-3 minute screening is all it takes to ensure that newborns in your hospital won't suffer complications or death from a missed diagnosis of CCHD? Congenital heart disease is the most common birth defect and accounts for almost 40% of deaths from congenital anomalies. Three out of every 1,000 babies are born with a severe form of CHD -- critical congenital heart disease (CCHD) -- and it is estimated that 2,000 will have a missed diagnosis or die. Nurses can help prevent complications from missing the diagnosis of CCHD by spending only a few minutes to screen newborns using pulse oximetry. Learn more and buy this webinar recording. Email this Story

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual AWHONN endorsements. The news reported in SmartBrief does not necessarily reflect the official position of AWHONN.
Association of Women’s Health, Obstetric and Neonatal Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

AWHONN is approved by the California Board of Registered Nursing, provider #CEP580.
Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director: Rebecca Adelson (202) 618-5665
Read more at SmartBrief.com
 Recent AWHONN SmartBrief Issues:   Editor: Tom Parks

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.® Legal Information